Vertex halts VX-264 trials after missing efficacy goals but continues advancing zimislecel, a potential treatment for severe ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...

Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to trigger sufficient levels of insulin production in a phase 1/2 trial.

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex Pharma has made its name with treatment for cystic fibrosis, but has big plans in cell and genetic therapies – and has just chalked up fast-track status from the FDA for a cell-based ...

See reviews below to learn more or submit your own review. How do I know I can trust these reviews about The Standard Insurance Company? How do I know I can trust these reviews about The Standard ...

Standard Capital Markets Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 95.15 Crore) operating in Financial Services sector. Standard Capital Markets Ltd. key ...

This dual-band CDMA camera phone sports a large 262,000-color main display, OLED outer display, voice dialing, voice memo, BREW (Get It Now), and 1xRTT high-speed data.

Acer Aspire VX-15 is a Windows 10 Home laptop with a 15.60-inch display that has a resolution of 1920x1080 pixels. It is powered by a Core i7 processor and it comes with 8GB of RAM. The Acer Aspire VX ...